CytomX Therapeutics Inc (NAS:CTMX)
$ 1.02 0 (0%) Market Cap: 79.82 Mil Enterprise Value: -27.17 Mil PE Ratio: 6.00 PB Ratio: 0 GF Score: 52/100

CytomX Therapeutics Inc Business and Strategy Update Call Transcript

Jul 13, 2022 / 10:00PM GMT
Release Date Price: $1.3 (+1.56%)
Operator

Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Strategic Update Call. Please (inaudible) recorded. I would now like to hand the call over to your host for today, Chau Cheng, CytomX's first Vice President, Investor Relations and Corporate Communications. Please go ahead.

Chau Cheng
CytomX Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Andrew. Good afternoon, everyone, and thank you for joining us. Before we begin, I'd like to remind everyone that during this call, we will be making forward-looking statements. Because forward-looking statements are related to the future, they are subject to inherent uncertainties and risks, including the uncertainty surrounding the COVID-19 pandemic that are difficult to predict and many of which are outside of our control. Important risks and uncertainties are set forth in our most recent public filings with the SEC at sec.gov. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future developments or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot